Annual EBITDA
$5.44B$1.54B+39.32%
Summary
- Current Value
- As of today, BSX annual EBITDA is $5.44B, up +39.32% on
- Historical Performance
- BSX annual EBITDA is up +83.75% over the past 3 years, up +215.67% over the past 5 years
- All-Time High Comparison
- BSX annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- BSX annual EBITDA is +83.75% above its 3-year low of $2.96B reached on an earlier date
- Sector Comparison
- BSX annual EBITDA is higher than 97.93% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $5.44B | +39.3% | +83.8% | +215.7% | +187.9% | |
| Quarterly EBITDA | $1.43B | +16.8% | +78.3% | +127.1% | +166.5% | |
| TTM EBITDA | $5.64B | +34.5% | +85.2% | +205.4% | +189.4% | |
| Price | $56.85 | -45.5% | +10.3% | +31.9% | +652.0% | |
| PE Ratio | 23.84 | -68.8% | -72.9% | -94.6% | +13.5% | |
| Annual Revenue | $20.07B | +19.9% | +58.3% | +102.5% | +157.2% | |
| Annual EPS | $1.94 | +55.5% | +334.9% | +2488.1% | +377.0% | |
| Annual EBIT | $3.97B | +50.7% | +117.7% | +560.7% | +270.1% | |
| Annual Net Income | $2.89B | +56.7% | +314.3% | +3626.8% | +371.6% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $5.44B | at high | |
| 5Y | $5.44B | at high | |
| All | $5.44B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $2.96B | N/A | +83.8% |
| 5Y | $1.72B | N/A | +215.7% |
| All | $73.90M | +7259.9% |
EBITDA History
FAQ
What is the current annual EBITDA of BSX?
As of today, BSX annual EBITDA is $5.44B
What is 1-year change in BSX annual EBITDA?
BSX annual EBITDA is up +39.32% year-over-year
What is 3-year change in BSX annual EBITDA?
BSX annual EBITDA is up +83.75% over the past 3 years
How far is BSX annual EBITDA from its all-time high?
BSX annual EBITDA is currently at its all-time high
How does BSX annual EBITDA rank versus sector peers?
BSX annual EBITDA is higher than 97.93% of companies in Healthcare sector
When is BSX next annual earnings release?
As of today, the next annual earnings release for BSX has not been scheduled
Quarterly EBITDA
$1.43B$151.00M-9.58%
Summary
- Current Value
- As of today, BSX quarterly EBITDA is $1.43B, down -9.58% on
- Historical Performance
- BSX quarterly EBITDA is up +16.79% year-over-year, up +78.25% over the past 3 years
- All-Time High Comparison
- BSX quarterly EBITDA is currently -9.58% below its historical high of $1.58B set on
- 3-Year Low Comparison
- BSX quarterly EBITDA is +78.25% above its 3-year low of $800.00M reached on an earlier date
- Sector Comparison
- BSX quarterly EBITDA is higher than 97.78% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $1.43B | -9.6% | +16.8% | +78.3% | +127.1% | |
| Annual EBITDA | $5.44B | – | +39.3% | +83.8% | +215.7% | |
| TTM EBITDA | $5.64B | +3.8% | +34.5% | +85.2% | +205.4% | |
| Price | $56.85 | -26.8% | -45.5% | +10.3% | +31.9% | |
| PE Ratio | 23.84 | -40.5% | -68.8% | -72.9% | -94.6% | |
| Quarterly Revenue | $5.20B | -1.6% | +11.6% | +53.5% | +89.1% | |
| Quarterly EPS | $0.90 | +99.6% | +98.7% | +332.3% | +292.6% | |
| Quarterly EBIT | $1.07B | -11.6% | +19.6% | +108.2% | +197.8% | |
| Quarterly Net Income | $1.34B | +99.8% | +99.3% | +326.4% | +292.7% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.58B | -9.6% | |
| 3Y | $1.58B | -9.6% | |
| 5Y | $1.58B | -9.6% | |
| All | $1.58B | -9.6% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.22B | N/A | +16.8% |
| 3Y | $800.00M | N/A | +78.3% |
| 5Y | $628.00M | N/A | +127.1% |
| All | -$95.70M | +1590.1% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of BSX?
As of today, BSX quarterly EBITDA is $1.43B
What is BSX quarterly EBITDA most recent change?
BSX quarterly EBITDA was down -9.58% on March 31, 2026
What is 1-year change in BSX quarterly EBITDA?
BSX quarterly EBITDA is up +16.79% year-over-year
How far is BSX quarterly EBITDA from its all-time high?
BSX quarterly EBITDA is currently -9.58% below its historical high of $1.58B set on December 31, 2025
How does BSX quarterly EBITDA rank versus sector peers?
BSX quarterly EBITDA is higher than 97.78% of companies in Healthcare sector
When is BSX next earnings release?
The next earnings release for BSX is on
TTM EBITDA
$5.64B$205.00M+3.77%
Summary
- Current Value
- As of today, BSX TTM EBITDA is $5.64B, up +3.77% on
- Historical Performance
- BSX TTM EBITDA is up +34.48% year-over-year, up +85.17% over the past 3 years
- All-Time High Comparison
- BSX TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- BSX TTM EBITDA is +85.17% above its 3-year low of $3.05B reached on an earlier date
- Sector Comparison
- BSX TTM EBITDA is higher than 97.87% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $5.64B | +3.8% | +34.5% | +85.2% | +205.4% | |
| Annual EBITDA | $5.44B | – | +39.3% | +83.8% | +215.7% | |
| Quarterly EBITDA | $1.43B | -9.6% | +16.8% | +78.3% | +127.1% | |
| Price | $56.85 | -26.8% | -45.5% | +10.3% | +31.9% | |
| PE Ratio | 23.84 | -40.5% | -68.8% | -72.9% | -94.6% | |
| TTM Revenue | $20.62B | +2.7% | +17.4% | +58.0% | +103.7% | |
| TTM EPS | $2.38 | +23.0% | +74.7% | +306.4% | +2338.3% | |
| TTM EBIT | $4.25B | +4.3% | +46.1% | +123.4% | +477.8% | |
| TTM Net Income | $3.56B | +23.1% | +75.8% | +294.6% | +1763.3% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $5.64B | at high | |
| 3Y | $5.64B | at high | |
| 5Y | $5.64B | at high | |
| All | $5.64B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $4.20B | N/A | +34.5% |
| 3Y | $3.05B | N/A | +85.2% |
| 5Y | $1.85B | N/A | +205.4% |
| All | -$24.90M | >+9999.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of BSX?
As of today, BSX TTM EBITDA is $5.64B
What is BSX TTM EBITDA most recent change?
BSX TTM EBITDA was up +3.77% on March 31, 2026
What is 1-year change in BSX TTM EBITDA?
BSX TTM EBITDA is up +34.48% year-over-year
How far is BSX TTM EBITDA from its all-time high?
BSX TTM EBITDA is currently at its all-time high
How does BSX TTM EBITDA rank versus sector peers?
BSX TTM EBITDA is higher than 97.87% of companies in Healthcare sector
When is BSX next earnings release?
The next earnings release for BSX is on
EBITDA Formula
Data Sources & References
- BSX Official Website www.bostonscientific.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/885725/000088572526000010/0000885725-26-000010-index.htm
- BSX Profile on Yahoo Finance finance.yahoo.com/quote/BSX
- BSX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bsx